NeuroTrials Research
  • Home
  • Be A Volunteer
    • Guide to Clinical Trials
    • Current Studies
    • What to Expect & FAQs
    • Interested in Clinical Research?
    • Refer a Friend
    • Helpful Information
  • About NTR
    • Who We Are
    • Choose NTR
    • Clinical Investigators
    • Tour our Research Site
  • Fact Sheet
  • Contact Us
Picture
Back to current studies
New Pathways for Parkinson's Disease

NeuroTrials Research is conducting a research study on the safety of a new study drug for Parkinson’s disease and patients with mild cognitive impairment (MCI). This non-motor symptom occurs in about 30% of people with Parkinson's. Those with MCI may complain of feeling distracted or forgetful, or losing their train of thought in conversation. 
. 
All study-related care & study drug will be provided at no cost, & qualified participants will receive compensation for time & travel. 

You may qualify if you:
  • are 40-85 years old
  • have been diagnosed with Parkinson’s Disease & experience MCI
  • are otherwise in general good health

For more information, call 404-851-9934 or complete the form below.

    Get started.

Submit
Picture
Neurotrials Research, Inc.
5887 Glenridge Drive, NE Suite 400
Atlanta, GA 30328
Picture
Contact Us:
tel: (404) 851-9934

fax: (404) 851-9458
Picture
Email Us:
info@neurotrials.com



  • Home
  • Be A Volunteer
    • Guide to Clinical Trials
    • Current Studies
    • What to Expect & FAQs
    • Interested in Clinical Research?
    • Refer a Friend
    • Helpful Information
  • About NTR
    • Who We Are
    • Choose NTR
    • Clinical Investigators
    • Tour our Research Site
  • Fact Sheet
  • Contact Us